# Global Medication Shortages: Comprehensive Report (2021-2024)

## Executive Summary

Medication shortages have become a critical global concern affecting both developed and developing countries between 2021 and 2024.

These shortages impact a wide range of medications including life-saving drugs for cancer, heart conditions, pain management, and other chronic illnesses.

As a caretaker for someone with multiple chronic conditions, understanding this landscape is crucial for ensuring continued access to essential medications.

## Scope of the Problem

The medication shortage crisis is widespread and affects numerous medication categories:

1.

**Cancer Medications**: Carboplatin and cisplatin, critical chemotherapy drugs, have experienced severe shortages.

By May 2023, the majority of cancer centers in the US were experiencing either complete absence or significant shortages of these medications, directly affecting patient treatment plans.

**Digestive Enzyme Replacements**: Creon 10,000, Creon 25,000, and Creonipe 35,000 (pancrelipase-based medicines) have been in short supply since at least October 2023, with contingent distribution expected to continue until December 31, 2025.

**Pain Management**: Intravenous (IV) paracetamol has faced critically low levels in hospitals across England.

This is particularly concerning as IV administration is significantly more effective (estimated 70% more effective) than oral tablets, especially for post-operative patients.

**Cardiovascular Medications**: Nitroglycerin, used to treat heart pain, has recently joined the growing list of medications facing shortages.

**Children's Medications**: Children's pain relievers and fever reducers, including products like Tylenol, have experienced increased demand of 20-40% above historical highs, creating supply challenges.

**Antibiotics**: Shortages of various antibiotics have been reported, though specific details were limited in the provided documents.

## Reasons Behind the Shortages

Multiple factors contribute to the global medication shortage crisis:

1.

**Production Issues**: Manufacturing capacity constraints have been cited as a primary reason for several shortages, including IV paracetamol in the UK and pancrelipase-based medicines in Italy.

**Increased Demand**: Consumer-driven demand has significantly increased for certain medications, particularly children's medications, with demand running 20-40% above historical highs.

**COVID-19 Pandemic Impact**: The pandemic disrupted pharmaceutical manufacturing as companies prioritized COVID-19 drug and vaccine development.

Manufacturing shutdowns to comply with regulations further impacted production of other essential medications.

**Economic Factors**:
   - In Egypt, a dollar crisis has affected the pharmaceutical industry's ability to import necessary raw materials.

- Production costs have increased significantly, causing losses for manufacturers.

- Production lines have not returned to pre-crisis efficiency levels.

**Supply Chain Vulnerabilities**: The global nature of pharmaceutical supply chains makes them susceptible to disruptions in any single region or manufacturing facility.

## Impact on Patients and Healthcare Systems

The medication shortages have had severe consequences:

1.

**Treatment Disruptions**: Cancer patients have been told, "I have a treatment for you.

I don't know if you'll get it.

I don't know when you'll get it.

I don't know what dose I can give you.

"

2.

**Compromised Care**: Hospitals have had to use less effective alternatives, such as replacing IV paracetamol with oral tablets that are only 30% as effective.

**Financial Burden**: Almost a third of US adults, including those with insurance, cannot afford their prescriptions.

This leads to:
   - Skipping doses or cutting pills in half (nearly 3 in 10 adults)
   - Not filling prescriptions
   - Long-term health complications
   - Some households purchasing medications outside the US to find lower prices

4.

**Disproportionate Impact**: Lower-income households, uninsured and underinsured populations, and racial minorities (Black, Latino, and Native American people) are more likely to face cost-related barriers to treatment.

## How Healthcare Systems Are Coping

Various strategies have been implemented to manage these shortages:

1.

**Contingent Distribution**: Italy has implemented contingent distribution systems for pancrelipase-based medicines, ensuring limited supplies are rationed to maintain therapeutic continuity for patients.

**Government Intervention**:
   - Italy established an ad hoc table to address issues regarding access, availability, and sustainability of pharmaceutical goods.

- The Egyptian Ministry of Health has held meetings with industry stakeholders to find solutions.

**Increased Production**: Manufacturers in some regions have increased production of affected medications, though this has not always kept pace with demand.

**Alternative Treatment Protocols**: Healthcare providers have been forced to modify treatment plans, use alternative medications, or prioritize patients based on clinical need.

**Affordability Programs**: In the US, programs like Federally Qualified Health Centers (offering sliding scale fees) and the federal 340B program (providing discounted medications) help some patients access medications despite cost barriers.

## Recommendations for Caretakers

As a caretaker for someone with chronic conditions requiring life-saving medications, consider the following strategies:

1.

**Early Refills**: Request prescription refills earlier than usual to build a small buffer supply.

**Communication with Healthcare Providers**: Maintain open communication with your parent's healthcare team about potential shortages affecting their specific medications.

**Insurance and Assistance Programs**: Explore all available insurance options and assistance programs, including:
   - Federally Qualified Health Centers
   - The 340B program
   - Manufacturer assistance programs
   - State and local assistance programs

4.

**Therapeutic Alternatives**: Discuss with healthcare providers whether there are effective alternative medications that could be substituted if shortages occur.

**Multiple Pharmacies**: Consider using multiple pharmacies to increase chances of finding medications in stock.

**International Options**: While not without risks, some households have purchased medications from other countries where prices are lower.

This should only be done with medical guidance and from reputable sources.

**Stay Informed**: Regularly check with the FDA, EMA, or your country's regulatory authority for updated information on medication shortages.

## Conclusion

Global medication shortages represent a complex, multifaceted challenge that requires coordinated efforts from manufacturers, regulators, healthcare providers, and policymakers.

For caretakers of patients with chronic conditions, proactive planning, communication with healthcare providers, and awareness of available resources are essential strategies for navigating this ongoing crisis.

While systemic solutions may take time to implement, being prepared and informed can help ensure continued access to life-saving medications for your parent.

# Global Medication Shortages: Comprehensive Report (2021-2024)

## Executive Summary

Medication shortages have become a critical global concern affecting both developed and developing countries between 2021 and 2024.

Title:

Content: The real reason for the Children’s Tylenol shortage

After two years of lockdowns, colds are back and consumers are likely hoarding. ‘We’re seeing increases in demand that are running close to 20 to 40 per cent.’

Kim Mackay has resorted to giving her 11-year-old son expired children’s Tylenol desperate to ease his pain.

The 44-year-old mother and her husband scoured the aisles of at least 10 pharmacies in Vancouver and Burnaby in British Columbia in search of the pain medication for their child’s pancreatitis but could not find the product on shelves.

After friends, also on the look out, came back empty-handed, Mackay posted a plea for help on Facebook.

“I managed to get some expired Tylenol from somebody, and another person had gone down to the U.S. in the last month and brought back a big pack of Tylenol so I have that too,” Mackay said, adding that she currently has enough medicine for another week or so. After that, she’s resigned to repeating her search.

“It has been stressful on top of my child’s illness but I’m grateful for the people who have helped,” Mackay said.

Drugstores nationwide have been grappling since May with supply shortages of over-the-counter medications for children containing acetaminophen (also known by the brand name Tylenol), and ibuprofen (Advil) due to heightened demand and supply chain constraints.

“After two-years of social distancing, kids, adolescents, even young adults are getting exposed again to regular viruses,” said Dr. Sumon Chakrabarti, an infectious disease physician in Toronto, adding that a resurgence of colds and flus was expected after lifting COVID-19 restrictions.

“Kids normally would have a certain level of immunity when they’re being exposed to viruses. But we’re seeing a general increase and kids getting sicker than they normally would have because of the last two years of social distancing,” said Chakrabarti.

Supply of pain relievers for children has been especially impacted by unprecedented demand driven by an uptick of cold and flu viruses as well, treatment for milder COVID-19 symptoms is impacting the supply, according to the Ontario Pharmacists Association.

“We have seen higher transmission of respiratory illnesses such as coughs, colds and COVID-19 since the relaxation of public health precautions,” said Jen Belcher, vice-president of the Ontario Pharmacists Association. “Manufacturers have been unable to keep up with the high demand for all these products,” she added.

The Retail Council of Canada, which deals with supply chain issues on behalf of retailers across Canada, said overall demand is outpacing production for children’s cold and flu medications.

“Retailers are experiencing rolling shortages,” said Retail Council of Canada spokesperson Michelle Wasylyshen. Staffing shortages at the manufacturing level are also impacting production, she added.

These drug shortages are primarily consumer-driven, said Anthony Fuchs, a spokesperson for Food, Health & Consumer Products of Canada, the national trade association representing Canada’s food, beverage and consumer goods manufacturer which includes pharmaceutical company Johnson & Johnson Inc., the maker of Tylenol, as a member.

While there are staffing shortages among all members, they “have not been identified to me by companies making these types of products as an issue,” said Fuchs. “These companies have increased production of the products that they’re providing but particularly when it comes to children’s medication, we’re seeing increases in demand that are running close to 20 to 40 per cent above historical highs,” Fuchs said.

When asked about shortages, Johnson & Johnson confirmed that it is continuing “to experience increased consumer-driven demand.”

“We are taking all possible measures to ensure product availability,” the email said.

Dr. Rupert Kaul, director of the division of infectious diseases at the University of Toronto, said demand could also be spiking because people are stock piling the drugs.

In August, Health Canada in a twitter post urged Canadians not to buy more acetaminophen and ibuprofen medications for children than necessary to prevent drug shortages.

“It may well be that people are panic-buying children’s Tylenol in the same way we were panic-buying toilet paper at the start of the pandemic without any true increase in use,” Kaul said.

He pointed out that acetaminophen can be made in certain pharmacies on-site, so there isn’t any worry that drug stores will run out of it, he said.

“If we can rein in any panic buying, it will reduce the pressure on those supplies so the people who need them will be able to access them,” Kaul said.

Ghada Alsharif is a Toronto-based staff reporter for the Star. Reach Ghada via email: galsharif@torstar.ca
JOIN THE CONVERSATION

Conversations are opinions of our readers and are subject to the Code of Conduct. The Star does not endorse these opinions.

More from The Star & Partners

More Business

Top Stories

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

These shortages impact a wide range of medications including life-saving drugs for cancer, heart conditions, pain management, and other chronic illnesses.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: ChatGPT's AI Chatbot Blur Your Home on Google Maps Gift Picks From CNET Editors 17 Superb Gift Ideas Lensa AI Selfies Guillermo del Toro's 'Pinocchio' Prepping for 'Avatar 2' 'Harry & Meghan' on Netflix
Want CNET to notify you of price drops and the latest stories?
No, thank you
Accept

Millions of Americans Can't Afford Their Prescription Drugs. Now What?

As the cost of medication soars, patients are turning to online coupons and financial assistance programs.

When 27-year-old Savanna Braun changed jobs last December, she had more to worry about than meeting co-workers and adapting to an unfamiliar schedule. A new job meant different insurance, and that meant jumping through hoops to get approval for her lifesaving prescription drugs.

With insurance coverage, which costs her around $5,100 a year, she pays an extra $960 annually for medications to treat her severe asthma, psoriatic arthritis and depression. Those pharmacy benefits soften the bill -- without insurance, she'd be looking at a staggering $200,000 a year.

As basic expenses increase, soaring prescription drug prices are eating up an even larger portion of household income. Over just the last year, prescription drug prices rose at an average rate of 31.6%, with some increasing up to 500%, according to a recent Department of Health and Human Services government report. Americans, who pay the highest prices in the world for prescription drugs -- two to three times more than people in other countries -- are finding any way possible to get around the entangled pharmaceutical industry.

Exorbitant prescription drug costs disproportionately hurt lower-income households, particularly the uninsured and underinsured populations (9% and 23% of US adults, respectively). Black, Latino and Native American people are less likely to have health insurance and more likely to face cost-related barriers to treatment, according to the Commonwealth Fund, a nonprofit focused on health policy reform. Without insurance, patients are forced to sacrifice their medications for more immediate needs, such as housing or food. Those who are reliant on prescription drugs to manage their chronic conditions can often accumulate medical debt

Almost a third of the US adult population, including those with insurance, can't take their prescriptions because they can't afford it, according to Frederick Isasi, executive director of the health advocacy group Families USA. The crisis has damaging consequences: Nearly three in 10 adults end up skipping doses, cutting pills in half or not filling their prescription, resulting in long-term health complications. Others get desperate -- as many as 8% of American households have purchased medications outside the US to get a lower price.

But there are far less risky workarounds. Some patients score significant cost savings by opting for generic medications, requesting alternative medication from their providers or even switching pharmacies. Others who are financially vulnerable turn to advocacy organizations, sliding-scale health centers or patient assistance plans. And many turn to third-party sites like GoodRx, NeedyMeds.org or, more recently, Mark Cuban's Cost Plus Drug Company to cost-compare medication prices, get coupons and save at the register.

When drug costs stand in the way of patient health

Braun had her first run-in with high-cost medicine when she was 3 years old. After she had a life-threatening asthma attack, her doctors said the best treatment was an adult-only prescription. The insurance company didn't want to cover a drug that wasn't approved for her age group by the Food and Drug Administration, though it eventually gave in.

Controlling her asthma soon became a whirlwind of nebulizers, inhalers and steroids, all of which cut into her family's budget. Every time her father changed jobs, she had to wait months until his benefits kicked in, and the bureaucratic obstacles to get her meds began again.

With the 2010 enactment of the Affordable Care Act, Braun's family could no longer be denied insurance coverage or charged more for her preexisting condition. But a few years later, after Braun was diagnosed with psoriatic arthritis, she struggled with trying to find the right medication, and most of them took months for insurance to authorize. Her list of tested drugs read like a pharmaceutical representative's brochure: Methotrexate, Humera, Solara, Remicade and Xeljanz. When her asthma worsened, her pulmonologist told her to take Xolair, but insurance initially denied her, saying she needed to have less lung function to warrant its use.

When Braun turned 26, she got kicked off her parents' insurance plan and lost coverage for all her medications. For months, she was stuck relying on her doctor's samples to keep her symptoms at bay. Not having access to her specialized drugs and treatment set her back. "I was losing lung function rapidly," Braun said, noting that she now has permanent lung damage from not being able to control her asthma. Braun was constantly worried about ending up on a ventilator in the hospital without insurance coverage. "I was pretty scared for my life," she said.

When insurance obstacles stand in the way of patient health

Julie Whitehead, 52, who has bipolar disorder, tackles similar insurance hurdles, which take a huge toll on her mental health. In 2015, Whitehead's doctor prescribed a new mood stabilizer, Abilify, but her insurance company balked. At the time, Abilify didn't have a generic option, so it would cost her $1,000 a month out of pocket.

Because Whitehead couldn't afford the hefty price tag, she was prescribed a different medication, Geodon, for her bipolar disorder. But after six months taking it, she became suicidal. "I had been in a good place for five years, and then I was hospitalized," Whitehead said.

In 2020, Whitehead's doctor wanted to change her medication to Latuda, which required prior authorization. Prior authorization requires a lot of time-consuming paperwork, and if doctors agree to do it, they often charge for it. Whitehead had to wait three months for a green light, and in the meantime she struggled to pay out of pocket for Latuda, which cost more than her monthly Social Security disability check. Luckily, Whitehead's husband had enough income to help her cover the cost. But the process made her angry -- she was trying to "forestall a medical catastrophe," and wasn't allowed to because of an insurance denial.

Today, Whitehead pays around $200 a month for her 11 prescriptions under her husband's insurance plan. "It's one thing to be without insurance and have to depend on Medicaid and Medicare Part D," she said. "But to pay a king's ransom for insurance and for it to still not cover what you need, that's in some ways worse."

A David versus Goliath fight

As many as 28% of adults end up having to take a prescription that isn't covered by their health insurance, and 13% have had a prescription medication dropped by their health insurance plan, according to a survey conducted by GoodRx Health. In 2016, Americans spent some $66 billion total for out-of-pocket retail prescription drugs.

Additionally, many pharmaceutical companies place the drugs that treat chronic diseases such as diabetes, asthma, HIV/AIDS and hepatitis B and C in higher specialty tiers with greater out-of-pocket prices. People of color are disproportionately impacted by these types of serious illnesses and health conditions, making such drug-tier policies openly discriminatory, according to the National Academy for Health Policy.

Disputing a denial from an insurance company for an important medication takes time and effort -- it also requires a certain amount of financial literacy and tools, which aren't generally accessible to historically disadvantaged groups. Some patients never try negotiating with or appealing to their providers or insurance companies on costs.

Vulnerable consumers going up against the pharmaceutical behemoth is a David and Goliath fight, according to Isasi. From 2000 to 2018, 35 pharmaceutical companies reported a combined $11.5 trillion in revenue. With so much in profits at stake, the pharmaceutical industry focuses its lobbying efforts on keeping drug prices high and reducing its competition by gaining monopoly power through patents.

While pharmaceutical companies claim that high drug prices are needed to cover research and development, a recent study conducted by an international team of researchers showed no association between pricing policies and R&D investments. Drug companies set the price, regardless of how much it costs to make the medication. "It's usually a half a penny, or one cent, to actually produce that drug," Isasi said. "Why is it that a drug company can charge whatever they can get away with?"

Alternative paths to obtaining affordable medicine

The debate over prescription drug prices has for decades taken center stage in congressional hearings and among lawmakers. The recently passed Inflation Reduction Act has an extremely limited provision allowing Medicare to annually negotiate prices with pharmaceutical companies on 10 pricey medications, starting in 2026. It also caps out-of-pocket prescription drug costs at $2,000 for those with Medicare Part D drug plans, but not until 2025.

A multitude of organizations focus exclusively on pushing common-sense reforms and achieving policy changes to lower the price of prescription drugs. But until there's a monumental overhaul to the global pharmaceutical industry, there are a few government-based solutions that help medically underserved populations obtain lifesaving medication. For example, Federally Qualified Health Centers offer a sliding scale for certain drugs, and the federal 340B program allows certain hospitals and clinics to buy discounted outpatient prescription drugs for low-income and uninsured patients.

The next step, according to Isasi, is for patients to check if they qualify for Medicaid, through the website. Though eligibility income levels are very low, the expansion of Medicaid in 39 states has helped many financially vulnerable households cover the cost of prescription drugs. And Medicare patients age 65 or older can try applying for the Extra Help federal program to get their medicine at a very reduced, income-adjusted rate.

Patients can also try looking for coupons, rebates or price comparisons online. GoodRx offers discount coupons for all FDA-approved medications, both brand name and generic, regardless of insurance status. If there isn't a GoodRx coupon available, the site will offer a coupon from the manufacturer to bring down the price, or show options for similar medications that may be more affordable, according to co-founder Doug Hirsch. Patients can present a GoodRx coupon to the pharmacy immediately, and the price is better than an insurance copay more than half the time, said Hirsch.

The Cost Plus Drug Company, launched by the billionaire Mark Cuban, is a new online pharmacy that slashes prices on generic prescription drugs. A recent study in the Annals of Internal Medicine, co-authored by Harvard Medical School fellow Dr. Hussain Lalani, found that Medicare could've saved $3.6 billion in 2020 if it purchased 77 prescription medications through Mark Cuban's company. Uninsured and underinsured patients get the biggest benefit from using Cost Plus, Lalani said. But patients should look elsewhere if they need a brand name or clinician-administered drug, or if they need their generic medication immediately, since generics from Cost Plus come through the mail.

Read more: How to Get Cheaper Prescription Medicine With Cost Plus Drugs

Then there's NeedyMeds.org, an organization started in 1997 by Dr. Richard J. Sagal, which assembles roughly 40,000 patient-assistance programs for people who can't afford medication and health care costs. It's a free, nonaffiliated information outlet, and visitors to the site are anonymous. Sagall said it receives up to 15,000 daily users looking for low-cost clinics, prescription savings, rebate programs and more. The organization also gets up to 6,000 calls a month to its toll-free hotline from patients seeking resources.

Sagall, a former family physician, said he's helping more people through the website than he ever did in private practice. "Our ultimate goal is to go out of business for lack of need," said Sagall. "I don't see that happening in the near future."

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Shortcomings Creon, confirmations from Aifa and the company: “Difficulties until the end of 2025”

#Shortcomings #Creon #confirmations #Aifa #company #Difficulties

Rome, 30 January – The situation of shortages on the pancreatic enzymes market, reported in recent days by the singer Fedez and ended up on the pages of newspapers, TV news and information sites, it had been addressed by AIFA since last autumn, when – after a discussion with the owner/sales licensee (Viatris Italia Srl) and in agreement with the same – the the national regulatory agency had issued an information note aimed at healthcare professionals which clearly represented the terms of the problem. The drug – which replaces the functions of the pancreas when compromised and is necessary for patients to assimilate food – began to register significant shortages on the distribution circuit in autumn 2023.

Due to production problems/high demand for pancrelipase-based medicines Creon 10,000, Creon 25,000 and Creonipe 35,000″ explained AIFA in the note dated 25 October 2023, “they are currently distributed on a contingent basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the regulatory authority in accordance with current legislation”.

AIFA therefore invited healthcare professionals to prescribe these drugs “only for authorized indications, to inform patients already undergoing treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 e Creonipe 35.000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if, for patients under treatment, it is not possible to switch to other medicines. This is to ensure that the available packaging, as limited, is used for indications for which the medicine cannot be replaced”.

The difficult situation has not seen any improvement since then but, in the meantime, reports of patients seeking the drug have multiplied, and Fedez has acted as spokesperson for this in recent days. On the problem – after the clarifications of Minister Schillaci in question time in the Senate in recent days, the undersecretary also spoke yesterday Marcello Gemmato (in the picture). who in a statement to Adnkronos wanted to remind you that “AIFA allows healthcare facilities to import similar medicines authorized abroad. In addition to this, I invite pharmacies, if they cannot find the drug from the usual suppliers, to place the order directly with the manufacturing company”.

“The situation has been under the attention of the Ministry of Health and the Italian Medicines Agency for some time, in constant dialogue with the manufacturing companyand to manage its supply in the area so that the therapeutic continuity of the medicine for citizens is guaranteed as much as possible” then reiterated Gemmato, who wanted to point out how the issue of the unavailability of some drugs in our country has been “one of the issues that I wanted to address, already in the first months as undersecretary, through the establishment of an ad hoc table to deal with all issues regarding access, availability and sustainability of pharmaceutical goods for citizens”.

Viatris itself, the company that holds the authorization to market and distribute Creon pancreatic enzymes in Italy, also intervened on the issue, requested by telephone from Ansa. “We are in daily contact with the manufacturing company to mitigate supply difficulties and reduce the impact on patients” company representatives told the agency, confirming the difficulty in supplying Creon. Which, however, they explain from Vatris, are due “in high demand globally” and not, as some initially hypothesized, “to issues of quality, safety or effectiveness”. In any case, the situation does not yet seem to be resolved. Indeed, as already announced last October, Viatris has confirmed that “difficulties in supply could continue until 12/31/2025”.

Also Read:  MPOX virus is spreading rapidly

Recent News

Editor's Pick

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: How the Chemotherapy Shortage Is Affecting Frontline Clinicians

— "How are we here in 2023 having some of these discussions?" bemoans gynecologic cancer expert

MedpageToday
  • Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan.

In this exclusive Instagram Live clip, Jeremy Faust, MD, editor-in-chief of MedPage Today, and Eleonora Teplinsky, MD, head of Breast and Gynecologic Medical Oncology for Valley-Mount Sinai Comprehensive Cancer Center in Paramus, New Jersey, discuss how the recent shortage of the chemotherapy mainstays cisplatin and carboplatin have impacted cancer patients and frontline clinicians.

The following is a transcript of their remarks:

Faust: Dr. Teplinsky, let me ask you about your side as a frontline clinician in this area. As an ER doctor, I don't type in, "Let's give a patient cisplatin." That's not an order that I put in. So, how long have you been seeing shortages like this that affect your patients?

Teplinsky: I would say around April -- again, talking about this particular shortage with carboplatin and cisplatin -- I think around April we started hearing about it. But it was one of those things, I'll be honest, where you're like, "Oh, this can't possibly happen. This is happening somewhere else. This isn't affecting us."

Then I think NBC ran an article on it. Then for a month nothing happened, and then all of a sudden, I would say in May, it really kind of exploded in the sense that many, [the] majority of cancer centers were either experiencing complete absence of drugs or shortage of drugs. They weren't able to procure it from their suppliers.

That quickly made its way to the patients not being able to get the drug, or having to sit in front of a patient and say, "I have a treatment for you. I don't know if you'll get it. I don't know when you'll get it. I don't know what dose I can give you."

And imagine, you're already facing this life-changing diagnosis, but there are drugs -- you just don't know when you'll get them. I think that we don't talk enough about that emotional toll that takes on patients, because the uncertainty that everyone was facing was really quite tragic.

Faust: When you had that conversation with a patient -- I guess it depends on the kind of cancer, doesn't it? Because there are certain oncologic conditions where we're so fortunate that we have many, many regimens. Maybe this one is a tiny bit better than that one and you're sort of scraping out on your Kaplan-Meier curves, your survival curves, a couple of months here. Are you able to reassure your patients, or does it really depend on the kind of cancer that we're talking about?

Teplinsky: It really depends on the kind of cancer.

I will say that the Society of Gynecologic Oncology really led the way with this because, unlike in other cancers where you can substitute, in gynecologic cancers it's really hard -- you need the platinum drugs. So they led the way. And then ASCO, the American Society of Clinical Oncology, followed and came up with guidelines for clinicians about when you can substitute, what you could substitute. Can we spread out the dosing, so instead of every 3 weeks, can we give it every 4 weeks to make the drug last longer? Can you reduce the dose?

Conversations that, again -- how are we here in 2023 and having some of these discussions? But that's kind of what happened.

The challenge really was: do we have data to substitute? Will you sacrifice the efficacy if you switch from one drug to another? Then as a result, if now everyone is shifting to this drug, do we have supply for the other drugs? So I think [they really were] very difficult discussions. And again, for some disease types we were able to make that switch, but not for all.

Faust: OK. I want to jump over in just a second to some of the policy side, but let me stick with you for one moment just to pursue that point a little further.

I study outcomes, mostly with COVID, but lots of other things too. But when you're making these switches, I know that in pediatric oncology, for example, they're always tweaking and testing and saying, "Let's compare A to B and see how they do." As this is happening, is this just too chaotic for anyone to stop and say, "Well, actually this is a little bit of an unfortunate opportunity to see well, are these biosimilars actually behaving decently comparably?" Or is it just too random for anything to be learned from this?

Teplinsky: Yeah, I think that it would've been great to be able to study, but it was too erratic because everyone was at different points in their treatment cycles. Some people had gotten five cycles and they had one more left. Other people were just starting out. Some of those patients we had to pivot and not do chemotherapy first, for example, and do surgery first where we normally wouldn't. So the circumstances and the situations were each too different to actually look at this in a cohesive way.

I do think that, fortunately, people moved fairly quickly to try to get drugs and try to increase supply. So we were in this bad point for a couple weeks, but it started to recover, but now we're seeing a different shortage of 5-fluorouracil.

I am curious about this from the policy side, but unless we really come up with long-term solutions, the short-term solutions are going to just lead us to another drug shortage in 3 more months for something else.

Faust: You mentioned the word "allocation" and that set off a thought that I wanted to talk about on the clinical side. So Dr. Teplinsky, we know that drugs don't reach every community equally, right? There are certainly "haves" and "have-nots" and the in-between. From the standpoint of oncology, do we sense that when shortages happen, there's a disparity in terms of who's affected?

Teplinsky: Absolutely. I mean, I think we have to keep in mind that the majority of patients are still treated in the community setting.

For this particular shortage, NCCN, the National Comprehensive Cancer Network, did a study of multiple NCCN sites and they found that about 93% were affected by the shortage in some way. What we don't have information on, again, is in terms of exactly which settings were more affected than others.

Understandably, patients, if they are treated in a community site that maybe is not a big center -- that's a small site that purchases a very small amount and didn't stockpile -- those people are going to be predominantly affected. And very often they cannot travel to a bigger site that has more resources if they're in a setting where this is the only site or they are limited by socioeconomic disparities.

Absolutely, this heightens the already ongoing disparities that we see in cancer treatment. Absolutely.

Faust: In terms of how that plays out for your patient population or your colleagues, does this lead to your job being a lot of case management, in a sense? You know the medicine, you know the drugs, but what you need to figure out is who has what and who can go where. Is that really where a lot of resources and your time get spent in your office?

Teplinsky: I mean, that's part of it.

I think the challenge too is that, a couple months ago, no one knew when more drugs would arrive. So a lot of places were also sharing with each other, but they were also hesitant about taking on new patients, right? Because if we can't even provide for our existing patients, what's that going to look like?

But I think the other piece that really is challenging is, if you do have a limited supply, who do you prioritize it to? This was something we saw in COVID also in terms of access to care when the pandemic was at its height. The same thing now: do you give [the drugs] to the person that is going to be cured, hopefully, with this, or someone who needs it for a palliative reason? But how do you make that distinction?

I think those are really challenging questions and really hard decisions for physicians to have to make.

Faust: What do you tell a friend -- not a patient, because a patient's coming to you and you're going to treat them -- if someone says, "Look, I got a biopsy and they're sending me to this oncology center or that one," would you tell them to look into this? You don't want to go down a pathway with a wonderful practice who actually can't treat you, when across the street for reasons that we just discussed a minute ago -- some negotiation or someone got it ahead of a stampede in a panic -- they have the drug.

Would you advise patients who are looking at this landscape to behave any differently than they would've in another environment?

Teplinsky: Absolutely. I mean, I'm a firm believer that patients have to be their best advocate and you have to be your own advocate. I think it's a very appropriate question to say when you're meeting a practice, "I know that my regimen is recommended to have carboplatin," for example, "Can you talk about where your institution or cancer center or hospital is with regards to these shortages?" I think that those are very valid questions.

Part of the things that we say: what should you ask your oncologist? I think in this space and time that we're in, that should be part of the list. Because again, like you said, you don't want to all be set up for treatment to find out that they don't actually have the drug.

I think the challenge is in patients who are not able to do that, who are not able to go somewhere else, and that's really hard.

Faust: Yeah. It's interesting to me, again, I'm an ER doctor, but I work in a pretty fancy magnet hospital. People always come to us for second opinions or for the magic stuff that Dana-Farber [Cancer Institute] might have, as if it's any different.

In some cases, look, we have wonderful experts and we have some experimental treatments that are unavailable everywhere else. But a lot of times when it's straightforward, I kind of feel like we've got a nation of really, really qualified oncologists. You don't need to fly halfway across the country to get first-line treatment. And yet, some people actually would do that. They want that name brand.

But now you could argue that the big-name brands are probably the ones that have the most purchasing power and bargaining power, so all of a sudden it might matter, right?

Teplinsky: Yeah, I think we don't know. And it varies. I mean, some of the biggest cancer centers were actually the ones experiencing some of the bigger shortages.

Faust: Oh, really?

Teplinsky: It was very variable throughout the country, but you could see on Twitter, people were sharing, "Who's got the drug? Who doesn't have the drug?" So it really was very surprising, actually, that this hospital had it, this cancer center didn't, and vice versa.

It's also such a fluctuating state, right? You might have it tomorrow, you might not have it the next week, which is why I think this was so hard for patients because there was no guarantee of when it would come back. I think that really exacerbated all of it as well.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

As a caretaker for someone with multiple chronic conditions, understanding this landscape is crucial for ensuring continued access to essential medications.

Title:

Content: The Egyptian alternative is not available.. and the importer increased 150% search for insulin..
A journey of misery that threatens the lives of diabetic patients
5.
There is no voice louder than the cries of patients who have failed to get their medicine.. The crisis of lack of medicines continues and haunting patients and threatening their lives.. The most prominent shortcomings of insulin.. In the new republic, access to insulin has become a difficult dream.
Insulin disappeared from pharmacies.. The Right to Medicine Association also received many complaints about the lack of insulin in public hospitals and health insurance clinics in the provinces.
Some patients resorted to the ambulance pharmacy in search of insulin, which is dispensed in specific quantities after providing a modern prescription and analysis proving the patient's diabetes, which prompted citizens to crowd in front of the ambulance pharmacy in long queues to buy those shortcomings after they disappeared from all pharmacies.
The lack of insulin prompted a number of patients to share their suffering on the social networking site Facebook and wondered where it was available.
The price of imported insulin pen rose from 62 pounds to 100 pounds and then 150 pounds up to 192 pounds.. The local price reaches 40 pounds, but it is not available only in the ambulance pharmacy and the patient spends one pen after submitting the prescription and a copy of the card and the analysis that proves the disease.
The crisis is not limited to pharmacies and government and university hospitals, but there is a shortage of insulin in health insurance pharmacies.
Many diabetic patients have complained of not being able to dispense their monthly treatment due to the lack of insulin.. The patient also has to pass through many pharmacies on a long journey to dispense his treatment and there are some pharmacies that dispense half the dose only because of the existing shortage.
The government held several meetings to discuss the drug shortage crisis and promised to solve it within a week.
The crisis prompted a number of deputies to submit requests for a briefing in the House of Representatives on the crisis of the shortage of medicines for chronic diseases such as heart, pressure and diabetes … and accused the Unified Procurement Authority and the Ministry of Health of failing to resolve the crisis.
Mohamed Elbahi, consultant of the Chamber of Pharmaceutical Industry at the Federation of Industries, said that the shortage of medicines in Egypt is caused by the high prices of raw materials due to the high exchange rate, as most of the raw materials used in the pharmaceutical industry are imported from abroad.
I forgot to solve the crisis in stages so as not to impose a burden on the citizen and expect the end of the crisis of medicine shortages within three months at the latest.
Although Egypt imports a large amount of insulin, the Minister of Health and Population, Dr. Khaled Abdel Ghaffar, said in statements that Egypt is a producer of insulin, and local insulin can be used as an alternative to the importer, but it is also not available.
As pointed out by dr.
Alaa Mohamed, a pharmacist, said that there is a prevailing culture among citizens that the importer is the best and despite the high price of imported insulin, but the patient is still looking for him and is not satisfied with the alternative.. There are patients suffering from diabetes for several years and they are accustomed to the importer and it is difficult to replace it with the Egyptian.
Dr. Ali Abdullah, director of the Center for Pharmaceutical Studies, explained that the reason for the shortage of medicines is the inability of the producing companies to bear the difference of money to import raw materials after the rise of the dollar price from 31 pounds to 49 pounds.
He pointed out the need to raise the awareness of citizens and change the prevailing culture that the importer is better than the local. We must educate patients to use alternative medicines because they are much cheaper than the importer, which costs us a lot of money.
He added that it is necessary to enact legislation to prevent the dispensing of medicines without prescription in order to prevent the withdrawal of medicines and their use for purposes other than those specified for them.
On the other hand, Dr. Ali Abdullah called for the need to reconsider the pricing of medicines with not forgetting the social and investment part of companies.. And the citizen to accept the increase in the prices of medicine, and also must control the market of medicines.. There are statements by Minister Dr. Khaled Abdel Ghaffar pointed out that the private sector represents 70% of medicines, and the government has 30%.. Unfortunately there is a large amount of government medicines private hospitals and pharmacies health insurance are leaked For the black market and the citizen does not find evidence in a syringe price of 200 pounds sold for 2000 pounds.. In a drug used in illegal abortion price of 11 pounds is now sold for 200 and 300 pounds although it is private government only.. And on the private level we find abuse in the use of drugs veterinarians sell veterinary drugs with feed..
And gynecologists and obstetricians sell the IUD at times its prices and hormonal injections as well.. Where is the legislation that governs this farce and where is the drug traceability that governs the medicine can.
Dr. Irene Saad, a member of the House of Representatives, pointed out that the reason for the shortage of medicines, especially medicines for chronic diseases, is the decline in the import of raw materials and the tendency of some factories and companies to stop production lines because of the lack of raw materials for the industry due to the high price of the dollar.
She stressed that the role of the state is to pay attention to the factories of the private business sector in the country, which can feed the gap in public hospitals and health insurance, and there is more interest in the city of medicine to serve the national industry, and there is a national strategy to localize the drug industry and rely on local alternatives.
It is possible to agree with the Ministry of Agriculture to provide animal gelatin.. Packaging materials.. Manufacturing these materials locally can save the final cost and reach a fair price for medicines..
Therefore, the state should give incentives to important production lines that fill a deficit.. There must be coordination between the Pharmaceutical Authority and the Ministry of Industry to identify the shortcomings and develop alternative plans to provide them at reasonable prices.
She pointed out that insulin, for example, from medicines should be in stock at least 6 months because of its great importance in providing health care to citizens, and there should be stock for all medicines, especially medicines for chronic diseases.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

## Scope of the Problem

The medication shortage crisis is widespread and affects numerous medication categories:

1.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

**Cancer Medications**: Carboplatin and cisplatin, critical chemotherapy drugs, have experienced severe shortages.

By May 2023, the majority of cancer centers in the US were experiencing either complete absence or significant shortages of these medications, directly affecting patient treatment plans.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Digestive Enzyme Replacements**: Creon 10,000, Creon 25,000, and Creonipe 35,000 (pancrelipase-based medicines) have been in short supply since at least October 2023, with contingent distribution expected to continue until December 31, 2025.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Pain Management**: Intravenous (IV) paracetamol has faced critically low levels in hospitals across England.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

This is particularly concerning as IV administration is significantly more effective (estimated 70% more effective) than oral tablets, especially for post-operative patients.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Cardiovascular Medications**: Nitroglycerin, used to treat heart pain, has recently joined the growing list of medications facing shortages.

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Children's Medications**: Children's pain relievers and fever reducers, including products like Tylenol, have experienced increased demand of 20-40% above historical highs, creating supply challenges.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Antibiotics**: Shortages of various antibiotics have been reported, though specific details were limited in the provided documents.

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

## Reasons Behind the Shortages

Multiple factors contribute to the global medication shortage crisis:

1.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

**Production Issues**: Manufacturing capacity constraints have been cited as a primary reason for several shortages, including IV paracetamol in the UK and pancrelipase-based medicines in Italy.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Increased Demand**: Consumer-driven demand has significantly increased for certain medications, particularly children's medications, with demand running 20-40% above historical highs.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**COVID-19 Pandemic Impact**: The pandemic disrupted pharmaceutical manufacturing as companies prioritized COVID-19 drug and vaccine development.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: There were 960 press releases posted in the last 24 hours and 185,355 in the last 365 days.

Pharmacogenomics Market is Estimated to Boom at a 10.8% CAGR by 2028 | Thermo Fisher Scientific, Abbott Laboratories

Pharmacogenomics

SEATTLE, UNITED STATES, UNITED STATES, January 13, 2022 /EINPresswire.com/ -- New Research Study "Pharmacogenomics Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.

Pharmacogenomics studies the role of the genome in drug response. This field of research combines pharmacology with genomics to study the genetic makeup of individuals. It is also becoming a valuable tool for personalized medicine. Because of its focus on individual response, pharmacogenomics is a valuable tool to identify new therapeutic targets. However, this field has its limitations. One of the main benefits of pharmacogenomics is that it may help identify the most effective treatment for certain mental illnesses. First-line treatments for depression often fail to work for a large proportion of patients.

Request a Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1053

Market Dynamics

Growing focus on precision medicine is expected to drive growth of the global pharmacogenomics market during the forecast period. Personalized medicine is manufactured specifically for unique individuals based on their predicted response or risk of disease. The demand for personalized medicine has increased in the recent past as physicians can provide more effective drugs and avoid potential side effects. For instance, in May 2021, AdventHealth partnered with Sema4 to launch a precision medicine program. Pharmacogenomics plays a major role in precision medicine by guiding pharmaceutical companies in drug discovery and development and also helping physicians in selecting the right drug for patients based on their genetic make-up.
However, challenges associated with reimbursement and difficulties in detecting gene variation that affects drug response are expected to hamper the global pharmacogenomics market growth over the forecast period.

Impact of COVID-19

The outbreak of the COVID-19 pandemic has significantly impacted the global pharmacogenomics market. With many pharmaceutical companies prioritizing drug discovery and vaccine development for novel coronavirus, the development of precision medicine for different types of chronic and acute diseases was massively impacted. Furthermore, manufacturing companies had to shut down their operations, in order to comply with regulations, which further impacted growth of the said market. However, the rollout of vaccines and many countries undertaking mass vaccination programs is expected to aid in regaining the lost traction of the market in the near future.

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1053

Key Takeaways

• The global pharmacogenomics market is expected to expand, exhibiting a CAGR of 10.8% over the forecast period. This is owing to increasing prevalence of chronic diseases such as tuberculosis, cancer, and HIV. According to the World Health Organization (WHO), in 2018, around 9.6 million died due to cancer with over 300,000 new cases of cancer being diagnosed each year among children aged 0-19 years across the globe.

• Among regions, North America is expected to witness significant growth in the global pharmacogenomics market during the forecast period. This is owing to the high presence of per capita healthcare expenditure and robust healthcare infrastructure in the region.

• Key companies involved in the global pharmacogenomics market are Abbott Laboratories Inc., AstraZeneca plc, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., and Qiagen.

The following are the study objectives for this report:

· SWOT Analysis focuses on worldwide main manufacturers to define, assess, and analyse market competition. By kind, application, and region, the market is defined, described, and forecasted.
· Examine the global and main regional market potential and advantage, opportunity and challenge, constraints and risks.
· Determine whether trends and factors are driving or limiting market growth.
· By identifying high-growth categories, stakeholders would be able to analyse market potential.
· Conduct a strategic study of each submarket's growth trends and market contribution.
· Expansions, agreements, new product launches, and acquisitions in the market are all examples of competitive developments.
· To create a strategic profile of the main players and analyse their growth plans in depth.

𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝗨𝗦𝗗 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.coherentmarketinsights.com/promo/buynow/1053

Mr.Shah
Coherent Market Insights
+1 2067016702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Manufacturing shutdowns to comply with regulations further impacted production of other essential medications.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Economic Factors**:
   - In Egypt, a dollar crisis has affected the pharmaceutical industry's ability to import necessary raw materials.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

- Production costs have increased significantly, causing losses for manufacturers.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

- Production lines have not returned to pre-crisis efficiency levels.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Supply Chain Vulnerabilities**: The global nature of pharmaceutical supply chains makes them susceptible to disruptions in any single region or manufacturing facility.

## Impact on Patients and Healthcare Systems

The medication shortages have had severe consequences:

1.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

**Treatment Disruptions**: Cancer patients have been told, "I have a treatment for you.

I don't know if you'll get it.

I don't know when you'll get it.

I don't know what dose I can give you.

"

2.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Compromised Care**: Hospitals have had to use less effective alternatives, such as replacing IV paracetamol with oral tablets that are only 30% as effective.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Financial Burden**: Almost a third of US adults, including those with insurance, cannot afford their prescriptions.

This leads to:
   - Skipping doses or cutting pills in half (nearly 3 in 10 adults)
   - Not filling prescriptions
   - Long-term health complications
   - Some households purchasing medications outside the US to find lower prices

4.

**Disproportionate Impact**: Lower-income households, uninsured and underinsured populations, and racial minorities (Black, Latino, and Native American people) are more likely to face cost-related barriers to treatment.

## How Healthcare Systems Are Coping

Various strategies have been implemented to manage these shortages:

1.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

**Contingent Distribution**: Italy has implemented contingent distribution systems for pancrelipase-based medicines, ensuring limited supplies are rationed to maintain therapeutic continuity for patients.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Government Intervention**:
   - Italy established an ad hoc table to address issues regarding access, availability, and sustainability of pharmaceutical goods.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

- The Egyptian Ministry of Health has held meetings with industry stakeholders to find solutions.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Increased Production**: Manufacturers in some regions have increased production of affected medications, though this has not always kept pace with demand.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Alternative Treatment Protocols**: Healthcare providers have been forced to modify treatment plans, use alternative medications, or prioritize patients based on clinical need.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Affordability Programs**: In the US, programs like Federally Qualified Health Centers (offering sliding scale fees) and the federal 340B program (providing discounted medications) help some patients access medications despite cost barriers.

## Recommendations for Caretakers

As a caretaker for someone with chronic conditions requiring life-saving medications, consider the following strategies:

1.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

**Early Refills**: Request prescription refills earlier than usual to build a small buffer supply.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Communication with Healthcare Providers**: Maintain open communication with your parent's healthcare team about potential shortages affecting their specific medications.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Insurance and Assistance Programs**: Explore all available insurance options and assistance programs, including:
   - Federally Qualified Health Centers
   - The 340B program
   - Manufacturer assistance programs
   - State and local assistance programs

4.

**Therapeutic Alternatives**: Discuss with healthcare providers whether there are effective alternative medications that could be substituted if shortages occur.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Shortcomings Creon, confirmations from Aifa and the company: “Difficulties until the end of 2025”

#Shortcomings #Creon #confirmations #Aifa #company #Difficulties

Rome, 30 January – The situation of shortages on the pancreatic enzymes market, reported in recent days by the singer Fedez and ended up on the pages of newspapers, TV news and information sites, it had been addressed by AIFA since last autumn, when – after a discussion with the owner/sales licensee (Viatris Italia Srl) and in agreement with the same – the the national regulatory agency had issued an information note aimed at healthcare professionals which clearly represented the terms of the problem. The drug – which replaces the functions of the pancreas when compromised and is necessary for patients to assimilate food – began to register significant shortages on the distribution circuit in autumn 2023.

Due to production problems/high demand for pancrelipase-based medicines Creon 10,000, Creon 25,000 and Creonipe 35,000″ explained AIFA in the note dated 25 October 2023, “they are currently distributed on a contingent basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the regulatory authority in accordance with current legislation”.

AIFA therefore invited healthcare professionals to prescribe these drugs “only for authorized indications, to inform patients already undergoing treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 e Creonipe 35.000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if, for patients under treatment, it is not possible to switch to other medicines. This is to ensure that the available packaging, as limited, is used for indications for which the medicine cannot be replaced”.

The difficult situation has not seen any improvement since then but, in the meantime, reports of patients seeking the drug have multiplied, and Fedez has acted as spokesperson for this in recent days. On the problem – after the clarifications of Minister Schillaci in question time in the Senate in recent days, the undersecretary also spoke yesterday Marcello Gemmato (in the picture). who in a statement to Adnkronos wanted to remind you that “AIFA allows healthcare facilities to import similar medicines authorized abroad. In addition to this, I invite pharmacies, if they cannot find the drug from the usual suppliers, to place the order directly with the manufacturing company”.

“The situation has been under the attention of the Ministry of Health and the Italian Medicines Agency for some time, in constant dialogue with the manufacturing companyand to manage its supply in the area so that the therapeutic continuity of the medicine for citizens is guaranteed as much as possible” then reiterated Gemmato, who wanted to point out how the issue of the unavailability of some drugs in our country has been “one of the issues that I wanted to address, already in the first months as undersecretary, through the establishment of an ad hoc table to deal with all issues regarding access, availability and sustainability of pharmaceutical goods for citizens”.

Viatris itself, the company that holds the authorization to market and distribute Creon pancreatic enzymes in Italy, also intervened on the issue, requested by telephone from Ansa. “We are in daily contact with the manufacturing company to mitigate supply difficulties and reduce the impact on patients” company representatives told the agency, confirming the difficulty in supplying Creon. Which, however, they explain from Vatris, are due “in high demand globally” and not, as some initially hypothesized, “to issues of quality, safety or effectiveness”. In any case, the situation does not yet seem to be resolved. Indeed, as already announced last October, Viatris has confirmed that “difficulties in supply could continue until 12/31/2025”.

Also Read:  MPOX virus is spreading rapidly

Recent News

Editor's Pick

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Multiple Pharmacies**: Consider using multiple pharmacies to increase chances of finding medications in stock.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**International Options**: While not without risks, some households have purchased medications from other countries where prices are lower.

Title:

Content: Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit

Local pharmacies are seeing a huge drug supply and demand problem

  • Updated
  • 0

TERRE HAUTE, Ind. (WTHI) - We're nearing the end of cold and flu season, but many people are still getting sick.

Right now, many pharmacies are having trouble getting the drugs their customers need. That means patients are paying more for the drugs they do have.

Have you had a hard time getting any of your medication?

You voted:

A new survey was released by the "National Community Pharmacists Association." The survey finds that several drugs are in high demand at independent pharmacies.

Shawna Henshaw is a local mom in Terre Haute. She says basic medications are flying off the shelves.

"It's been kind of harder to get something to combat the cold and the flu. When we do find something, I'm grabbing it real quick, so I can feel better," said Henshaw.

Recently, she says she has been having trouble finding basic drugstore medications for her daughter and herself.

"I don't like to drive all around downtown trying to find something. I'll stop by something locally, but a lot of times, I have to drive around time to find it," said Henshaw.

Haley Funkhouser is the Pharmacist Technician at "Vigo Health Pharmacy."

In the past month, she says there has been a "40% price increase" on average in common medications. some are even more than that. This is due to inflation, discontinuations, and supply chain issues. With more people coming into the pharmacy sick, pharmacists can't keep up with demand.

Some drugs seeing an increase in prices are, Adderall, antibiotics, nebulizer solutions, child relief medicine and diabetes medication.

"We could not get in some insulin 'forever'. We couldn't get Trulicity, we couldn't get Ozempic, we couldn't get Mounjaro," said Funkhouser.

Funkhouser has kids of her own. She says these problems have also affected her family.

"As a mother myself, I had a hard time finding antibiotics for my two children, so I totally understand what people are going through. It's extremely frustrating," said Funkhouser.

With spring approaching, Henshaw hopes prices will decrease soon, but she says people still need their medications...Regardless of the prices.

"It's one of those things that people, you know if we have a short of this, we raise the price. People are still gonna buy it anyways," said Henshaw.

If people have trouble finding their medications, the pharmacy urges people to call their doctors and see if another similar drug is available.

Recommended for you

This should only be done with medical guidance and from reputable sources.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

**Stay Informed**: Regularly check with the FDA, EMA, or your country's regulatory authority for updated information on medication shortages.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Shortcomings Creon, confirmations from Aifa and the company: “Difficulties until the end of 2025”

#Shortcomings #Creon #confirmations #Aifa #company #Difficulties

Rome, 30 January – The situation of shortages on the pancreatic enzymes market, reported in recent days by the singer Fedez and ended up on the pages of newspapers, TV news and information sites, it had been addressed by AIFA since last autumn, when – after a discussion with the owner/sales licensee (Viatris Italia Srl) and in agreement with the same – the the national regulatory agency had issued an information note aimed at healthcare professionals which clearly represented the terms of the problem. The drug – which replaces the functions of the pancreas when compromised and is necessary for patients to assimilate food – began to register significant shortages on the distribution circuit in autumn 2023.

Due to production problems/high demand for pancrelipase-based medicines Creon 10,000, Creon 25,000 and Creonipe 35,000″ explained AIFA in the note dated 25 October 2023, “they are currently distributed on a contingent basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the regulatory authority in accordance with current legislation”.

AIFA therefore invited healthcare professionals to prescribe these drugs “only for authorized indications, to inform patients already undergoing treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 e Creonipe 35.000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if, for patients under treatment, it is not possible to switch to other medicines. This is to ensure that the available packaging, as limited, is used for indications for which the medicine cannot be replaced”.

The difficult situation has not seen any improvement since then but, in the meantime, reports of patients seeking the drug have multiplied, and Fedez has acted as spokesperson for this in recent days. On the problem – after the clarifications of Minister Schillaci in question time in the Senate in recent days, the undersecretary also spoke yesterday Marcello Gemmato (in the picture). who in a statement to Adnkronos wanted to remind you that “AIFA allows healthcare facilities to import similar medicines authorized abroad. In addition to this, I invite pharmacies, if they cannot find the drug from the usual suppliers, to place the order directly with the manufacturing company”.

“The situation has been under the attention of the Ministry of Health and the Italian Medicines Agency for some time, in constant dialogue with the manufacturing companyand to manage its supply in the area so that the therapeutic continuity of the medicine for citizens is guaranteed as much as possible” then reiterated Gemmato, who wanted to point out how the issue of the unavailability of some drugs in our country has been “one of the issues that I wanted to address, already in the first months as undersecretary, through the establishment of an ad hoc table to deal with all issues regarding access, availability and sustainability of pharmaceutical goods for citizens”.

Viatris itself, the company that holds the authorization to market and distribute Creon pancreatic enzymes in Italy, also intervened on the issue, requested by telephone from Ansa. “We are in daily contact with the manufacturing company to mitigate supply difficulties and reduce the impact on patients” company representatives told the agency, confirming the difficulty in supplying Creon. Which, however, they explain from Vatris, are due “in high demand globally” and not, as some initially hypothesized, “to issues of quality, safety or effectiveness”. In any case, the situation does not yet seem to be resolved. Indeed, as already announced last October, Viatris has confirmed that “difficulties in supply could continue until 12/31/2025”.

Also Read:  MPOX virus is spreading rapidly

Recent News

Editor's Pick

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

## Conclusion

Global medication shortages represent a complex, multifaceted challenge that requires coordinated efforts from manufacturers, regulators, healthcare providers, and policymakers.

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: Shortcomings Creon, confirmations from Aifa and the company: “Difficulties until the end of 2025”

#Shortcomings #Creon #confirmations #Aifa #company #Difficulties

Rome, 30 January – The situation of shortages on the pancreatic enzymes market, reported in recent days by the singer Fedez and ended up on the pages of newspapers, TV news and information sites, it had been addressed by AIFA since last autumn, when – after a discussion with the owner/sales licensee (Viatris Italia Srl) and in agreement with the same – the the national regulatory agency had issued an information note aimed at healthcare professionals which clearly represented the terms of the problem. The drug – which replaces the functions of the pancreas when compromised and is necessary for patients to assimilate food – began to register significant shortages on the distribution circuit in autumn 2023.

Due to production problems/high demand for pancrelipase-based medicines Creon 10,000, Creon 25,000 and Creonipe 35,000″ explained AIFA in the note dated 25 October 2023, “they are currently distributed on a contingent basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the regulatory authority in accordance with current legislation”.

AIFA therefore invited healthcare professionals to prescribe these drugs “only for authorized indications, to inform patients already undergoing treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 e Creonipe 35.000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if, for patients under treatment, it is not possible to switch to other medicines. This is to ensure that the available packaging, as limited, is used for indications for which the medicine cannot be replaced”.

The difficult situation has not seen any improvement since then but, in the meantime, reports of patients seeking the drug have multiplied, and Fedez has acted as spokesperson for this in recent days. On the problem – after the clarifications of Minister Schillaci in question time in the Senate in recent days, the undersecretary also spoke yesterday Marcello Gemmato (in the picture). who in a statement to Adnkronos wanted to remind you that “AIFA allows healthcare facilities to import similar medicines authorized abroad. In addition to this, I invite pharmacies, if they cannot find the drug from the usual suppliers, to place the order directly with the manufacturing company”.

“The situation has been under the attention of the Ministry of Health and the Italian Medicines Agency for some time, in constant dialogue with the manufacturing companyand to manage its supply in the area so that the therapeutic continuity of the medicine for citizens is guaranteed as much as possible” then reiterated Gemmato, who wanted to point out how the issue of the unavailability of some drugs in our country has been “one of the issues that I wanted to address, already in the first months as undersecretary, through the establishment of an ad hoc table to deal with all issues regarding access, availability and sustainability of pharmaceutical goods for citizens”.

Viatris itself, the company that holds the authorization to market and distribute Creon pancreatic enzymes in Italy, also intervened on the issue, requested by telephone from Ansa. “We are in daily contact with the manufacturing company to mitigate supply difficulties and reduce the impact on patients” company representatives told the agency, confirming the difficulty in supplying Creon. Which, however, they explain from Vatris, are due “in high demand globally” and not, as some initially hypothesized, “to issues of quality, safety or effectiveness”. In any case, the situation does not yet seem to be resolved. Indeed, as already announced last October, Viatris has confirmed that “difficulties in supply could continue until 12/31/2025”.

Also Read:  MPOX virus is spreading rapidly

Recent News

Editor's Pick

Title:

Content: Egyptian News
Mohsen Hassan for DMC: Solving the Drug Shortage Crisis in the Next Few Weeks
Ahmed Wael Omar - Cairo on Tuesday, April 30, 2024 12: 36 AM - Dr. Mohsen Hassan, director of the commercial sector in one of the pharmaceutical companies in Egypt, said that in 2019 the Egyptian Drug Authority was established, a historic leap in the Egyptian pharmaceutical industry, pointing out that there are procedures to ensure the quality, effectiveness and safety of the drug starting from the raw material where it is analyzed more than once.
Mohsen Hassan added during an interview with the program "evening dmc", on the channel dmc, that the production processes of the drug are analyzed more than analysis, and the random withdrawal of the can inside the pharmacy, and change the raw material takes the same steps as the previous one again, and the matter has a large control percentage.
Mohsen Hassan stressed that after the state provided the dollar, it is now available to buy any raw materials, and the shortage of medicine is on the way to solve in the next few weeks, pointing out that the guarantee of the quality of the Egyptian product as a medicine is compared to the "brand".
He pointed out that the pharmaceutical companies are committed to any legislation or decisions of the medical authorities, which is an important part of the medical system and we have a great role in providing high quality treatment and a suitable price for the Egyptian patient, stressing that the Egyptian medicine during the recent period is comparable to foreign medicines, and 90% of the cans sold in the Egyptian market are produced by Egyptian companies.
Advertisements
You may also read.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
Sammy is patient.
The pharmaceutical industry reveals the date of solving the shortage crisis..
God will show it to us
The head of the Chamber of Pharmaceutical Industry at the Federation of Industries, Dr. Jamal Al-Laithi, said that the pharmaceutical sector is suffering from a crisis due to the monthly dollar measures required for the sector, estimated at about $250 million per month to secure needs, whether raw materials or finished medicine, pointing out that the pharmaceutical market is witnessing shortages in some types of medicines by 30%.
Jamal al-Laithi added during a telephone interview with the media Lamees al-Hadidi that "the factories are operating at about 70% of their capacity and this will have a negative impact during the coming period if it continues, as it affects the shortages of medicine and on the other hand the economies of factories."
He pointed out that Prime Minister Dr. Mostafa Madbouly is following this file with great interest, as we participated as a room in the meeting today in the presence of a ministerial group and the Central Bank and there are assurances on the management of the dollar during the coming period and Dr. Madbouly requested this from the Central Bank.
He pointed out that, however, the coming period needs two parts, the first part is the release of raw materials in ports and airports, estimated at about $97 million, and this will be managed urgently, as well as the promise to meet the monthly needs of the sector, estimated at about $250 million.
He stressed that over the past two months, one dollar of the total monthly needs of $250 million has been provided only by 20% of the amount at a rate of 10% per month, expressing his hope for a breakthrough in the crisis.
He revealed that the most important types that are experiencing a shortage are some colon and glands drugs, antibiotics and some sugar drugs.
On the situation of medical supplies, he said that the situation is more secure and stable because it includes life-threatening supplies such as corneas and stents, and sent a message of reassurance to citizens: “Do not worry the crisis will resolve soon and God will show it to us. ”

Title:

Content: PEI

Nitroglycerin latest medication shortage

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

‘This isn’t the only medication that is shorted’

Nitroglycerin, which is used to treat heart pain, has been difficult to come by recently, joining a long list of drugs that have faced shortfalls in the last few years.

"It is frustrating because this isn't the only medication that is shorted," said Sheri Koshman, a cardiac pharmacist and professor in the cardiology division at the University of Alberta.

"There's all kinds of medication that is shorted all the time, and it's always this circle that goes round and round and round."

In recent months shortages of painkillers and antibiotics have also been reported.

Nitroglycerin can be used for long-term control and quick relief of heart pain, and it is the latter type where there is a shortage. Nitroglycerin dilates arteries and veins, so someone with blockages in their heart arteries can use it to open them up a little more.

For some people, nitroglycerine is an option they keep on hand but rarely use, and they will probably be OK during this shortage, said Koshman. The drug is safe to use up to a year after its expiry date, she said.

"We're telling people who have chest pain and are having to use their nitroglycerine regularly, and are perhaps running out, that they should probably see their physician to have their chest pain control reassessed," said Koshman.

"People that are needing it, and often, they should probably be reassessed by their health-care provider anyway."

The drug is really a pain treatment, and in that way not critical, she said. The important thing when experiencing heart pain is to sit down and rest. Giving your heart a break will also ease the pain.

If it doesn't go away, said Koshman, then you should seek emergency care. You may be having a heart attack.

With files from Island Morning

now

For caretakers of patients with chronic conditions, proactive planning, communication with healthcare providers, and awareness of available resources are essential strategies for navigating this ongoing crisis.

While systemic solutions may take time to implement, being prepared and informed can help ensure continued access to life-saving medications for your parent.

Title:

Content: Shortcomings Creon, confirmations from Aifa and the company: “Difficulties until the end of 2025”

#Shortcomings #Creon #confirmations #Aifa #company #Difficulties

Rome, 30 January – The situation of shortages on the pancreatic enzymes market, reported in recent days by the singer Fedez and ended up on the pages of newspapers, TV news and information sites, it had been addressed by AIFA since last autumn, when – after a discussion with the owner/sales licensee (Viatris Italia Srl) and in agreement with the same – the the national regulatory agency had issued an information note aimed at healthcare professionals which clearly represented the terms of the problem. The drug – which replaces the functions of the pancreas when compromised and is necessary for patients to assimilate food – began to register significant shortages on the distribution circuit in autumn 2023.

Due to production problems/high demand for pancrelipase-based medicines Creon 10,000, Creon 25,000 and Creonipe 35,000″ explained AIFA in the note dated 25 October 2023, “they are currently distributed on a contingent basis; this situation will presumably continue until 12/31/2025. The shortage is not due to safety or quality issues and has already been communicated to the regulatory authority in accordance with current legislation”.

AIFA therefore invited healthcare professionals to prescribe these drugs “only for authorized indications, to inform patients already undergoing treatment also in order to avoid hoarding phenomena and to prescribe Creon 10,000 and 25,000 e Creonipe 35.000 only if strictly necessary, in the minimum effective dose, and if for the indication in question there are no valid therapeutic alternatives or if, for patients under treatment, it is not possible to switch to other medicines. This is to ensure that the available packaging, as limited, is used for indications for which the medicine cannot be replaced”.

The difficult situation has not seen any improvement since then but, in the meantime, reports of patients seeking the drug have multiplied, and Fedez has acted as spokesperson for this in recent days. On the problem – after the clarifications of Minister Schillaci in question time in the Senate in recent days, the undersecretary also spoke yesterday Marcello Gemmato (in the picture). who in a statement to Adnkronos wanted to remind you that “AIFA allows healthcare facilities to import similar medicines authorized abroad. In addition to this, I invite pharmacies, if they cannot find the drug from the usual suppliers, to place the order directly with the manufacturing company”.

“The situation has been under the attention of the Ministry of Health and the Italian Medicines Agency for some time, in constant dialogue with the manufacturing companyand to manage its supply in the area so that the therapeutic continuity of the medicine for citizens is guaranteed as much as possible” then reiterated Gemmato, who wanted to point out how the issue of the unavailability of some drugs in our country has been “one of the issues that I wanted to address, already in the first months as undersecretary, through the establishment of an ad hoc table to deal with all issues regarding access, availability and sustainability of pharmaceutical goods for citizens”.

Viatris itself, the company that holds the authorization to market and distribute Creon pancreatic enzymes in Italy, also intervened on the issue, requested by telephone from Ansa. “We are in daily contact with the manufacturing company to mitigate supply difficulties and reduce the impact on patients” company representatives told the agency, confirming the difficulty in supplying Creon. Which, however, they explain from Vatris, are due “in high demand globally” and not, as some initially hypothesized, “to issues of quality, safety or effectiveness”. In any case, the situation does not yet seem to be resolved. Indeed, as already announced last October, Viatris has confirmed that “difficulties in supply could continue until 12/31/2025”.

Also Read:  MPOX virus is spreading rapidly

Recent News

Editor's Pick